MATAWAN, N.J. & MOSCOW, Idaho, November 10, 2025--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) ("Apimeds") today announced the expansion of its ai² Futures Lab™ program ...
Futures Lab identified 45+ therapeutic opportunities on a $33,000 budget, expands to 13 university partners with 100% retention, and uncovers assets representing more than $500 million in prior ...
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced the continued participation of the University of Georgia’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results